Skip to content

Nakamoto, Inc. NAKA Inventories Net

Inventories Net at other companies

Sylvamo logo
SylvamoSLVM
$11M-52.2%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$7.1M+35.6%
Novanta logo
NovantaNOVT
$78.6M+41.8%
AZZ logo
AZZAZZ
$3.4M-12.8%
Syntec Optics Holdings, Inc. logo
Syntec Optics Holdings, Inc.OPTX
$585.87K+5.9%
Mesa Laboratories logo
Mesa LaboratoriesMLAB
$8.32M-14.9%

Other financials

Income statement

See full
Revenue$1.6M+177%
Operating income-$126.2M-12,008%
Net income-$238.8M-22,903%
EPS (diluted)-$0.38-124%

Balance sheet

See full
Cash & equivalents$35.3M+2,994%
Total debt$496.0K-37.6%
Total equity$367.1M+23,907%
Total assets$620.8M+24,115%

Cash flow

See full
Operating cash flow-$23.3M-2,592%
CapEx$2.0
Free cash flow-$901.5K-332%

Valuation

See full
Market cap$68.74M-39.6%
P/S24.1×-26.7×

Profitability

See full
Operating margin-11,313%-11,486pp
Net margin-4,568.7%-4,676pp
FCF margin-113.5%-131pp

Returns & leverage

See full
Return on equity-37.6%
Debt / equity-0.3×
Current ratio0.3×-2.0×

Where this comes from

Reported directly by Nakamoto, Inc. in its filing.

Tagged under the XBRL concept NAKA:InventoriesNet.

The official record: Nakamoto, Inc. ’s 10-K, filed March 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nakamoto, Inc. 's inventories net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nakamoto, Inc. 's inventories net?
Nakamoto, Inc. (NAKA) reported inventories net of $4.3K in Q4 2024.
What does inventories net mean?
The net value of medical supplies, pharmaceuticals, or clinical materials held by the company for use in patient care, adjusted for any reserves or obsolescence. This metric tracks the efficiency of supply chain management and inventory turnover within the clinical setting. Maintaining optimal levels is critical to ensuring uninterrupted patient service while minimizing carrying costs.